Unlock instant, AI-driven research and patent intelligence for your innovation.

Products for screening modulators of lrpprc and methods of identifying modulators of lrpprc

A regulator, R14 technology, applied in the field of biomedicine, can solve the problems of system instability, easy degradation of RNA, lack of

Active Publication Date: 2021-06-04
INST OF CHEM CHINESE ACAD OF SCI
View PDF3 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Second, the design and screening of enzyme activity inhibitors for proteases is extremely dependent on the understanding of protein structure. In the absence of protein crystal structures, the screening of protein inhibitors will face great challenges
Taking the RNA-binding protein LRPPRC as an example, in order to screen small molecule regulators that can block the binding of LRPPRC to RNA, it is necessary to know the nucleic acid characteristics of LRPPRC binding, that is, the conserved binding domain (motif). Most of the motifs of LRPPRC binding to RNA, even if the motif of LRPPRC binding to mRNA is known, in vitro transcription and recovery of RNA still have a very complicated operation process, and RNA is easily degraded, which may easily lead to system instability

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Products for screening modulators of lrpprc and methods of identifying modulators of lrpprc
  • Products for screening modulators of lrpprc and methods of identifying modulators of lrpprc
  • Products for screening modulators of lrpprc and methods of identifying modulators of lrpprc

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0037] Verification of the specific binding of nucleic acid aptamer R14 to LRPPRC

[0038] Co-immunoprecipitation method proves that LRPPRC protein specifically binds to nucleic acid aptamer R14

[0039]1) Collect the cells by centrifugation, and collect the cell lysate by centrifugation at 12000g after lysis;

[0040] 2) Synthesize biotin-labeled AS1411 and R14, AS1411 is a reported specific binding protein nucleolin

[0041] Nucleic acid aptamer; R14 is the nucleic acid aptamer obtained by LRPPRC protein screening, wherein R14:

[0042] GGTGGGTGGGTTGGGTGG;

[0043] AS1411: GGTGGTGGTGGTTGTGGTGGTGGTGG), dissolved in water, made into a 100nM storage liquid;

[0044] 3) with 5mM MgCl 2 The PBS configuration protein-aptamer mixture, protein 500ug, nucleic acid aptamer 200pm, final volume 1ml;

[0045] 4) After the protein-aptamer mixture was reacted at room temperature for 30 minutes, 50ul streptavidin-coated beads were added to recover the biotin-labeled aptamer-protein com...

Embodiment 2

[0049] Fragmentation of LRPPRC protein, proving that aptamer R14 binds to the C-terminus of LRPPRC protein

[0050] 1) According to the sequence characteristics of LPRRC protein, design and cut LRPPRC into 5 fragments, which are respectively denoted as LRP1-LRP5, specifically as figure 2 shown;

[0051] 2) integrating all LRPPRC fragments into the GST expression plasmid, performing prokaryotic expression and purification in Escherichia coli, and dissolving the obtained LRPPRC prokaryotic expression protein in PBS;

[0052] 3) Prepare LRPPRC fragmented protein-biotin-labeled R14 mixture, protein fragment 100ug, biotin-labeled R14 200pmol, final volume 1ml;

[0053] 4) After the LRPPRC fragment protein-R14 mixture was reacted at room temperature for 30 minutes, 50ul streptavidin-coated beads were added to recover the biotinylated R14-LRPPRC fragment protein complex;

[0054] 5) After washing the obtained R14-LRPPRC fragment protein complex with PBS three times, add 30ul prote...

Embodiment 3

[0057] In order to verify whether the nucleic acid aptamer-LRPPRC protein polarization screening system is suitable for a high-throughput drug screening system, this example is verified through the following two aspects:

[0058] 1): Screening system specificity validation

[0059] After FITC-labeling nucleic acids, verify the specificity of the system

[0060] 1) Prokaryotic expression and purification of LRPPRC protein, GST protein as a control protein, and BCA method for quantification;

[0061] 2) Synthesize the LRPPRC-specific nucleic acid aptamer Aptamer (R14, GGTGGGTGGGTTGGGTGG) labeled with fluorescein (including but not limited to fluorescent labeling methods such as HEX, CY3, and CY5) and an irrelevant control sequence (control DNA, AATTTTTAATTATTTATATTA), configured at 100 nM stock solution;

[0062] 2) The complex of configuration protein and nucleic acid sequence, the concentration of LRPPRC-specific nucleic acid aptamer and irrelevant control sequence are all 1...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The embodiment of the present invention discloses a product for screening LRPPRC modulators and a method for identifying LRPPRC modulators, including a kit and a device, and the kit includes recombinant LRPPRC protein, GST protein, fluorescein-labeled nucleic acid aptamer R14, and a fluorescein-labeled control nucleic acid; the device includes a multi-well plate and a fluorescence polarization signal detector. The embodiment of the present invention uses a short nucleic acid aptamer, which has a shorter sequence and molecular weight than the naturally occurring RNA and DNA sequences, which ensures that the polarization signal detection window is large enough in the screening process, so that the detection The signal-to-noise ratio is well guaranteed; there is no need for detailed crystal structure analysis of the target protein in advance, which can greatly reduce the threshold for drug screening; this screening method has good versatility for nucleic acid-binding proteins and is easy to promote.

Description

technical field [0001] The embodiments of the present invention relate to the field of biomedicine, in particular to a product for screening LRPPRC modulators and a method for identifying LRPPRC modulators. Background technique [0002] Molecular targeted therapy is the theoretical basis for disease treatment at this stage, including tumors, cardiovascular system, and nervous system diseases, all of which are in urgent need of clinically available specific molecular inhibitors. At this stage, drug design and development for protein targets are mainly limited in the following two aspects: first, drug development is mainly aimed at organisms with kinase activity, and the targeted drugs developed are mainly to inhibit the enzymatic activity of proteins, such as cancer In treatment, gefitinib inhibits EGFR kinase activity, dasatinib inhibits SRC kinase activity, cardiovascular system statins inhibit HMG-CoA reductase activity, and so on. However, the protein species with enzyma...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): G01N33/535G01N33/533G01N33/68G01N21/64
CPCG01N21/6428G01N33/533G01N33/535G01N33/6854G01N2021/6439
Inventor 方晓红周卫徐丽张振赵立波
Owner INST OF CHEM CHINESE ACAD OF SCI